$CURR CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins
https://finance.yahoo.com/news/cure-pharmaceu...00414.html
https://finance.yahoo.com/news/cure-pharmaceu...00414.html